€ 175 million
$ 195.079 million
Announced
5/12/2018
Prin Shasiharan - Researcher
Luxembourg
Netherlands
Switzerland
United Kingdom
Investment grade bond/note issue
Capital markets : Debt
Pharmaceuticals and life sciences
Party: Cosmo Pharmaceuticals (Issuer)